Tech Company Financing Transactions
Ultraleap Funding Round
British Patient Capital, CMB Capital and IP Group participated in a $82 million Series D capital raise for Ultraleap. This VC investment round closed on 11/19/2021.
Transaction Overview
Company Name
Announced On
11/19/2021
Transaction Type
Venture Equity
Amount
$82,000,000
Round
Series D
Proceeds Purpose
The raise will enable Ultraleap to further develop and commercialise its revolutionary technologies for existing and next generation computing platforms.
Company Information
Company Status
Private & Independent
Industry
Electronics
Mailing Address
2522 Leghorn St.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Ultraleap's world-leading hand tracking and unrivalled mid-air haptic technologies allow you to engage with the digital world naturally - without touching surfaces. No touchscreens. No controllers. No keypads. From enhancing 2D screens to developing fully immersive 3D experiences, Ultraleap powers natural, safe and effortless digital interaction in the increasingly connected world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Tobin
Chief Executive Officer
Thomas Carter
Chief Financial Officer
Chris Olds
President
Alain Bismuth
VP - Human Resources
Anne-Sofie Lagander
VP - Operations
Brian Williams
VP - Product Management
Anders Hakfelt
Browse more venture capital transactions:
Prev: 11/19/2021: Fountain Therapeutics venture capital transaction
Next: 11/19/2021: UNest venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs